1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Malignant Ascites Global Clinical Trials Review, H1, 2014

Malignant Ascites Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Malignant Ascites Global Clinical Trials Review, H1, 2014" provides data on the Malignant Ascites clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Ascites. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malignant Ascites. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Malignant Ascites Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Malignant Ascites 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Malignant Ascites to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Malignant Ascites to Oncology Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Malignant Ascites 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Malignant Ascites Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Neopharm Ltd. 28
Clinical Trial Overview of Neopharm Ltd. 28
Sanofi 29
Clinical Trial Overview of Sanofi 29
MRC Biotech Pty Ltd 30
Clinical Trial Overview of MRC Biotech Pty Ltd 30
Clinical Trial Overview of Top Institutes / Government 31
The Royal Marsden NHS Foundation Trust 31
Clinical Trial Overview of The Royal Marsden NHS Foundation Trust 31
Japan Interventional Radiology in Oncology Study Group 32
Clinical Trial Overview of Japan Interventional Radiology in Oncology Study Group 32
Masonic Cancer Center 33
Clinical Trial Overview of Masonic Cancer Center 33
AIO-Studien-gGmbH 34
Clinical Trial Overview of AIO-Studien-gGmbH 34
Chiba University 35
Clinical Trial Overview of Chiba University 35
Peking University 36
Clinical Trial Overview of Peking University 36
Huazhong University of Science and Technology 37
Clinical Trial Overview of Huazhong University of Science and Technology 37
Nihon University 38
Clinical Trial Overview of Nihon University 38
Baylor College of Medicine 39
Clinical Trial Overview of Baylor College of Medicine 39
North Central Cancer Treatment Group 40
Clinical Trial Overview of North Central Cancer Treatment Group 40
Five Key Clinical Profiles 41
Appendix 126
Abbreviations 126
Definitions 126
Research Methodology 127
Secondary Research 127
About GlobalData 128
Contact Us 128
Disclaimer 128
Source 129

List of Tables
Malignant Ascites Therapeutics, Global, Clinical Trials by Region, 2014* 6
Malignant Ascites Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Malignant Ascites Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Malignant Ascites Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Malignant Ascites Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Malignant Ascites Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Malignant Ascites Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Malignant Ascites to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Malignant Ascites Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Malignant Ascites Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Malignant Ascites to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Malignant Ascites Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Malignant Ascites Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Malignant Ascites Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Malignant Ascites Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Malignant Ascites Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Malignant Ascites Therapeutics, Global, Withdrawn Clinical Trials, 2014* 22
Malignant Ascites Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Malignant Ascites Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Malignant Ascites Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Malignant Ascites Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Malignant Ascites Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Malignant Ascites Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by Neopharm Ltd., 2014* 28
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 29
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by MRC Biotech Pty Ltd, 2014* 30
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by The Royal Marsden NHS Foundation Trust, 2014* 31
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Interventional Radiology in Oncology Study Group, 2014* 32
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2014* 33
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by AIO-Studien-gGmbH, 2014* 34
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2014* 35
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by Peking University, 2014* 36
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by Huazhong University of Science and Technology, 2014* 37
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by Nihon University, 2014* 38
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014* 39
Malignant Ascites Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2014* 40

List of Figures
Malignant Ascites Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Malignant Ascites Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Malignant Ascites Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Malignant Ascites Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Malignant Ascites Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Malignant Ascites Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Malignant Ascites to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Malignant Ascites Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Malignant Ascites Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Malignant Ascites to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Malignant Ascites Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Malignant Ascites Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Malignant Ascites Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Malignant Ascites Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Malignant Ascites Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Malignant Ascites Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Malignant Ascites Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Malignant Ascites Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Malignant Ascites Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 127

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.